Selected Publications

Daniel Lenihan, Michelle Bloom, Robert Copeland-Halperin, Matthew R Fleming, Michael Fradley, Rupal O'Quinn, Seema A Bhat : Considerations for the practical management of cardiovascular risk with Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia. Oncologist 30(9), 2025.

Stefano H Byer, Aravinthasamy Sivamurugan, Udhayvir S Grewal, Michael G Fradley, Paari Dominic: Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy. American Journal of Cardiology 243: 15-18, 2025.

Kerry A Rogers, Benyam Muluneh, Zaina P Qureshi, Jinghua He, Alex Bokun, Zhijie Ding, Marie-Hélène Lafeuille, Priyanka Gogna, Bruno Emond, Michael Fradley : A comparison of healthcare resource utilization and costs between patients with chronic lymphocytic leukemia treated with first-line ibrutinib or acalabrutinib using two large US real-world databases. Journal of Comparative Effectiveness Research 14(6), 2025.

Poojita Shivamurthy, Marisa Cevasco, Gregory E Supple, Balaram Krishna Hanumanthu, Timothy M Markman, Gustavo Guandalini, Matthew C Hyman, Andres Enriquez, Ramanan Kumareswaran, Michael G Fradley, Rajat Deo, Vincent Y See, Michael Riley, Fermin Garcia, Saman Nazarian, David Lin, David S Frankel, Sanjay Dixit, Andrew E Epstein, David J Callans, Francis E Marchlinski, Robert D Schaller : Epicardial placement of implantable cardioverter-defibrillators in adults: Technical considerations, system performance, and clinical outcomes. Heart Rhythm 22(10), 2025.

Sarah Turecamo, Lauren B Beach, Nosheen Reza, Monika Sanghavi, Michael G Fradley, Lauren Eberly : Gaps in Knowledge and Confidence Among Cardiologists in Caring for Transgender and Gender Diverse Patients. JACC Advances 2025.

Susan Dent, Heather Moore, Michael Fradley, Chloe Grace Rose, Stella Stergiopoulos, Connie Chen, Benjamin Li, Avirup Guha : QT STAR: concomitant QTc-prolonging medication use among patients with HR+/HER2- metastatic breast cancer receiving a CDK4/6 inhibitor in first line. Cardiooncology 11(1), 2025.

Malak El-Rayes, Mohamed Adam, Jiming Fang, Xuesong Wang, Irene Jeong, Peter C Austin, Andrew C T Ha, Michael G Fradley, Thomas A Boyle, Eitan Amir, Paaladinesh Thavendiranathan, Husam Abdel-Qadir: The Association of Malignancy With Stroke and Bleeding in Atrial Fibrillation: A Population-Based Cohort Study. JACC CardioOncology 7(2): 157-167, 2025.

Matthew A Barrett, Biniyam G Demissei, Ray Hu, Amanda M Smith, Gary Freedman, John Plastaras, Steven Feigenberg, Eva Berlin, Hari K Narayan, Benedicte Lefebvre, Marielle Scherrer Crosbie, Michael Fradley, Joseph Carver, Jinbo Chen, Bonnie Ky : 3D Echocardiographic Phenotyping of Left Ventricular Mechanics and Function With Contemporary Radiation Therapy. Advances in Radiation Oncology 10(7), 2025.

Stephen C Cook, Geoffrey D Barnes, Kathryn Berlacher, Quinn Capers 4th, Michael G Fradley, Leigh C Reardon, Anne Rzeszut, Melanie Sulistio, Melvin Echols : Experiences of Lesbian, Gay, Bisexual, Transgender, and Queer Cardiology Physicians and Fellows in Training. JACC Advances 4(2), 2025.

Lakshya Seth, Nickolas Stabellini, Shawn Doss, Vraj Patel, Viraj Shah, Gregory Lip, Susan Dent, Michael G Fradley, Lars Køber, Avirup Guha: Atrial fibrillation and ischemic stroke in cancer: the latest scientific evidence, current management, and future directions. Journal of Thrombosis and Thrombolysis 2025.